CCM — Concord Medical Services Holdings Share Price
- $23.08m
- $997.75m
- CNY537.40m
- 20
- 92
- 42
- 51
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 0.87 | ||
Price to Sales | 0.36 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -8.97% | ||
Return on Equity | n/a | ||
Operating Margin | -84.66% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CNYm | 198.36 | 223.01 | 485.63 | 472.08 | 537.4 | n/a | n/a | 23% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Concord Medical Services Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive solutions for cancer medical treatment. The Company operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The Company mainly conducts its business in the domestic market.
Directors
- Jianyu Yang CHM (50)
- Yaw Kong Yap PRE (57)
- Fu Xiao COO (54)
- Matthew Callister OTH (51)
- Zheng Cheng DRC (58)
- Yue Yu DRC (37)
- Weibo Yin IND (90)
- Boxun Zhang IND (45)
- Liping Zhang IND (49)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- November 27th, 2007
- Public Since
- December 11th, 2009
- No. of Employees
- 727
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
New York Stock Exchange
- Shares in Issue
- 130,251,685

- Address
- Room 26A1-26A5, East Tower, Hanwei, Buil, BEIJING, 100020
- Web
- https://www.concordmedical.com/
- Phone
- +86 1058256867
- Contact
- Edward Zhang
- Auditors
- Shandong Haoxin Certified Public Accountants Co., Ltd.
Upcoming Events for CCM
Similar to CCM
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ardent Health Partners
New York Stock Exchange
Auna SA
New York Stock Exchange
FAQ
As of Today at 20:02 UTC, shares in Concord Medical Services Holdings are trading at $5.32. This share price information is delayed by 15 minutes.
Shares in Concord Medical Services Holdings last closed at $5.32 and the price had moved by +5.52% over the past 365 days. In terms of relative price strength the Concord Medical Services Holdings share price has underperformed the S&P500 Index by -2.6% over the past year.
The overall consensus recommendation for Concord Medical Services Holdings is Sell. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreConcord Medical Services Holdings does not currently pay a dividend.
Concord Medical Services Holdings does not currently pay a dividend.
Concord Medical Services Holdings does not currently pay a dividend.
To buy shares in Concord Medical Services Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $5.32, shares in Concord Medical Services Holdings had a market capitalisation of $23.08m.
Here are the trading details for Concord Medical Services Holdings:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: CCM
Based on an overall assessment of its quality, value and momentum Concord Medical Services Holdings is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Concord Medical Services Holdings is $1.20. That is 77.43% below the last closing price of $5.32.
Analysts covering Concord Medical Services Holdings currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Concord Medical Services Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -26.84%.
As of the last closing price of $5.32, shares in Concord Medical Services Holdings were trading -10.31% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Concord Medical Services Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $5.32.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Concord Medical Services Holdings' management team is headed by:
- Jianyu Yang - CHM
- Yaw Kong Yap - PRE
- Fu Xiao - COO
- Matthew Callister - OTH
- Zheng Cheng - DRC
- Yue Yu - DRC
- Weibo Yin - IND
- Boxun Zhang - IND
- Liping Zhang - IND